Pulmonary Cancer

27 registered clinical trials studyying Pulmonary Cancer — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Differe NCT07236177	Poitiers University Hospital	EARLY_Phase 1
Recruiting	Tunisian Lung Cancer Study NCT06934499	Dacima Consulting	—
Recruiting	Precision Lung Cancer Survivorship Care Intervention NCT05857995	Jerod L Stapleton, PhD	N/A
Recruiting	Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Or NCT05977803	Assistance Publique - Hôpitaux de Paris	N/A
Unknown	The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer NCT06102369	Indonesia University	—
Unknown	A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection NCT05781581	RenJi Hospital	—
Unknown	Main Postoperative Complications After COVID-19 NCT05694949	RenJi Hospital	—
Unknown	Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections NCT05545085	Frisius Medisch Centrum	—
Recruiting	Erector Spinae Block for Thoracic Surgery NCT05521789	George Washington University	Phase 4
Completed	Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance NCT05915221	Trakya University	N/A
Completed	Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® NCT05011890	UNC Lineberger Comprehensive Cancer Center	N/A
Active Not Recruiting	Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation NCT04699188	Novartis Pharmaceuticals	Phase 1 / Phase 2
Completed	Cios Mobile 3D Spin for Robotic Bronchoscopy NCT04740047	Mayo Clinic	—
Completed	Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung NCT02410603	Mayo Clinic	—
Unknown	18F-FSPG PET/CT Imaging in Patients With Cancers NCT03144622	National Taiwan University Hospital	—
Terminated	MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) NCT02673021	Mayo Clinic	N/A
Completed	Quantification of microRNAs in Diagnosis of Pulmonary Nodules NCT03293433	University Hospital, Toulouse	—
Terminated	Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma NCT02549638	Mayo Clinic	—
Completed	An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors NCT02616211	Mayo Clinic	—
Completed	A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System NCT02370303	Mayo Clinic	—
Completed	Study of Arsenic Trioxide in Small Cell Lung Cancer NCT01470248	Emory University	Phase 2
Completed	A Phase I Study of iPS Cell Generation From Patients With COPD NCT01860898	Mayo Clinic	N/A
Completed	Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease NCT02476526	VA Greater Los Angeles Healthcare System	Phase 4
Terminated	Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cance NCT00511576	Mirati Therapeutics Inc.	Phase 1
Completed	First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation NCT00344773	AstraZeneca	Phase 2
Completed	Multidisciplinary Rehabilitation After Cancer Pulmonis Operation NCT01048762	Aalborg University Hospital	Phase 2
Completed	Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer NCT00098085	Agenus Inc.	Phase 2